Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 3 |
Nike
NKE
|
+$1.17B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$922M |
| 5 |
Hewlett Packard
HPE
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.13B |
| 3 |
Broadcom
AVGO
|
+$625M |
| 4 |
UnitedHealth
UNH
|
+$584M |
| 5 |
Mastercard
MA
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Healthcare | 7.41% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLBR
5626
DELISTED
Colombier Acquisition Corp II
CLBR
| $158K | ﹤0.01% |
14,877
-41,096
| -73% | -$444K |
|
5627
Lineage Cell Therapeutics
LCTX
$287M
| $158K | ﹤0.01% |
350,103
-34,963
| -9% | -$20.5K |
|
5628
Cato Corp
CATO
$66.1M
| $158K | ﹤0.01% |
47,437
+20,521
| +76% | +$68.9K |
|
5629
Pyxis Oncology
PYXS
$215M
| $158K | ﹤0.01% |
160,830
-23,872
| -13% | -$31.9K |
|
5630
Identive
INVE
$63.6M
| $157K | ﹤0.01% |
49,295
+17,811
| +57% | +$62.5K |
|
5631
Laird Superfood
LSF
$47.5M
| $157K | ﹤0.01% |
25,476
-11,000
| -30% | -$74.1K |
|
5632
Mastech Digital
MHH
$93.9M
| $157K | ﹤0.01% |
15,330
-6,190
| -29% | -$75.6K |
|
5633
Invivyd
IVVD
$191M
| $155K | ﹤0.01% |
255,970
+5,817
| +2% | +$5.22K |
|
5634
AirSculpt Technologies
AIRS
$348M
| $155K | ﹤0.01% |
66,285
-12,527
| -16% | -$56.2K |
|
|
APLT
5635
DELISTED
Applied Therapeutics
APLT
| $155K | ﹤0.01% |
316,230
-705,377
| -69% | -$415K |
|
5636
Lifetime Brands
LCUT
$185M
| $154K | ﹤0.01% |
31,260
-2,375
| -7% | -$12.9K |
|
5637
Commercial Vehicle Group
CVGI
$150M
| $154K | ﹤0.01% |
133,611
-43,852
| -25% | -$84.9K |
|
5638
Diana Shipping
DSX
$321M
| $153K | ﹤0.01% |
98,161
-28,150
| -22% | -$51.1K |
|
5639
XBiotech
XBIT
$68.9M
| $153K | ﹤0.01% |
47,182
-6,548
| -12% | -$22.6K |
|
|
FARM
5640
DELISTED
Farmer Brothers
FARM
| $153K | ﹤0.01% |
68,833
+49,374
| +254% | +$106K |
|
|
AARD
5641
Aardvark Therapeutics
AARD
$158M
| $153K | ﹤0.01% |
+20,311
| New | +$228K |
|
5642
Duluth Holdings
DLTH
$157M
| $152K | ﹤0.01% |
87,615
+29,521
| +51% | +$79.8K |
|
|
ACTU
5643
Actuate Therapeutics
ACTU
$29M
| $151K | ﹤0.01% |
22,358
+11,105
| +99% | +$89.2K |
|
5644
Silicom
SILC
$253M
| $151K | ﹤0.01% |
+10,147
| New | +$165K |
|
5645
Epsilon Energy
EPSN
$168M
| $151K | ﹤0.01% |
+21,333
| New | +$139K |
|
5646
PUT
TeraWulf
WULF
$8.96B
| $150K | ﹤0.01% |
+55,100
| New | +$245K |
|
5647
Roadzen
RDZN
$107M
| $150K | ﹤0.01% |
144,213
+30,305
| +27% | +$40.7K |
|
5648
Nautilus Biotechnolgy
NAUT
$112M
| $148K | ﹤0.01% |
171,787
-23,908
| -12% | -$35.5K |
|
|
CLYM
5649
Climb Bio
CLYM
$767M
| $147K | ﹤0.01% |
120,742
-4,562
| -4% | -$7.4K |
|
5650
Arqit Quantum Warrants
ARQQW
$160K
| $146K | ﹤0.01% |
72,319
| – | – |
|
Similar funds
Goldman Sachs's Q1 2025 Portfolio in Review
As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs's Q1 2025 filing shows 547 new, 2,373 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
- Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
- Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
- Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
- Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
- Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.